WASHINGTON, D.C. — In a decisive move to combat the rising rates of maternal mortality in the United States, the Association of Women’s Health, Obstetric and Neonatal Nurses (AWHONN) has announced the receipt of a $500,000 grant from Merck for Mothers. This significant investment is earmarked for the development and nationwide implementation of the POST-BIRTH Triage Index (PBTI), a first-of-its-kind standardized tool designed to revolutionize how emergency departments, urgent care centers, and freestanding medical facilities identify and treat life-threatening postpartum complications.
n
As the United States continues to grapple with a maternal health crisis that sees higher mortality rates than any other developed nation, this initiative aims to bridge a lethal gap in the "fourth trimester"—the critical year following childbirth. By providing non-obstetric clinicians with the specialized tools needed to recognize postpartum emergencies, the PBTI seeks to turn the tide on preventable deaths.
n
n
Main Facts: Addressing the "Invisible" Patient
n
The core of the AWHONN initiative is the development of the POST-BIRTH Triage Index (PBTI). While many hospitals have robust protocols for labor and delivery, a significant disconnect exists once a patient is discharged. When a postpartum individual experiences a medical emergency days or weeks after giving birth, they rarely return to the labor and delivery ward; instead, they seek care at the nearest emergency department (ED) or urgent care center.
n
In these high-pressure, non-obstetric settings, the fact that a patient is "postpartum" is often overlooked or undervalued in the triage process. A headache may be dismissed as stress or dehydration rather than identified as a symptom of late-onset preeclampsia. Shortness of breath might be attributed to anxiety instead of postpartum cardiomyopathy or a pulmonary embolism.
n
The $500,000 grant from Merck for Mothers—the pharmaceutical giant’s global initiative to end maternal mortality—will fund the creation of a validated, evidence-based index. This tool will function similarly to the Emergency Severity Index (ESI) but will be specifically calibrated to the physiological nuances of the postpartum body. The PBTI will provide a standardized language and assessment framework for clinicians who do not specialize in obstetrics, ensuring that postpartum patients are prioritized and treated with the urgency their condition requires.
n
n
Chronology: From Warning Signs to Systemic Solutions
n
The journey toward the PBTI began with AWHONN’s recognition that patient education, while vital, was only half the battle. For years, the organization has spearheaded the POST-BIRTH Warning Signs (PBWS) program. This initiative currently reaches over 1.7 million patients annually, providing them with discharge education on "red flag" symptoms such as heavy bleeding, chest pain, and extreme swelling.
n
However, feedback from the field revealed a harrowing trend: even when patients recognized their own warning signs and sought help, the healthcare system was not always prepared to receive them. The chronology of this new initiative reflects a shift from patient-centered education to system-centered intervention:
n
- n
- Pre-2026: The Research Phase: Investigations conducted across 23 emergency departments in 17 states highlighted a systemic failure. The data showed that clinicians in non-obstetric settings lacked the specific training and standardized tools necessary to differentiate a standard medical complaint from a postpartum emergency.
- July 2026: The Grant Award: Merck for Mothers officially awards $500,000 to AWHONN to bridge this gap.
- Late 2026: Expert Panel Assembly: AWHONN will convene a multidisciplinary expert panel, including emergency physicians, triage nurses, obstetricians, and maternal-fetal medicine specialists, to begin drafting the index.
- 2027 and Beyond: Validation and Implementation: The project will move into a phase consisting of three consecutive research studies to validate the index’s efficacy. This will be followed by the rollout of clinical protocols and the expansion of maternal and newborn education resources nationwide.
n
n
n
n
n
This timeline represents a multi-year commitment to changing the infrastructure of emergency medicine, ensuring that the progress made in labor and delivery rooms is not lost in the general waiting rooms of the nation’s hospitals.
n
n
Supporting Data: The Stark Reality of the Fourth Trimester
n
The necessity of the PBTI is underscored by sobering statistics provided by the Centers for Disease Control and Prevention (CDC) and various maternal mortality review committees.
n
According to current data, more than 50% of pregnancy-related deaths occur between seven and 365 days after delivery. This "late postpartum" period is the most dangerous and the least monitored. Even more striking is the consensus among experts that over 80% of these deaths are considered preventable with timely and appropriate medical intervention.
n
The research that prompted this grant focused on the "front lines" of care. In a study of 23 emergency departments, it was found that:
n
- n
- Identification Gaps: Postpartum patients were often not identified as such during the initial triage intake.
- Symptom Misinterpretation: Critical indicators of postpartum hemorrhage or infection were frequently miscategorized under general internal medicine codes, leading to longer wait times.
- Lack of Specialized Training: Fewer than 15% of emergency department nurses reported receiving specific training on postpartum complications within the last three years.
n
n
n
n
By implementing a standardized index, AWHONN aims to address these data points directly. The PBTI is designed to reduce the "time to treatment," a metric that is often the difference between life and death in cases of sepsis or hypertensive crisis.
n
Official Responses: A Shared Commitment to Survival
The leadership of both AWHONN and Merck for Mothers emphasized that this partnership is born out of a shared sense of urgency regarding the American maternal health crisis.
Jonathan Webb, MBA, MPH, the CEO of AWHONN, highlighted the vulnerability of the postpartum period. "This investment represents a significant step forward in improving maternal safety during one of the most vulnerable periods in a woman’s healthcare journey," Webb stated. "By developing the first validated postpartum-specific triage index for emergency and urgent care settings, we can help clinicians identify life-threatening complications more quickly, improve care coordination and ultimately save lives. We are grateful to Merck for Mothers for partnering with us to advance innovative, evidence-based solutions."
Representing the philanthropic arm of the donor, Jacquelyn Caglia, Head of Merck for Mothers, focused on the right to quality care. "Merck for Mothers believes that every mother deserves access to high-quality, timely care throughout the postpartum period," Caglia said. "We are honored to support AWHONN’s efforts to expand this important work, building on the success of the Post-Birth Warning Signs program and helping to strengthen systems providing care for families across the United States during this critical time."
These statements reflect a growing movement within the healthcare industry to move beyond "awareness" and toward the implementation of hard clinical standards that hold systems accountable for patient outcomes.
Implications: Redefining the Standard of Care
The implementation of the POST-BIRTH Triage Index carries profound implications for the future of maternal health, healthcare equity, and clinical practice.
1. Closing the Gap in Health Equity
Maternal mortality in the U.S. disproportionately affects Black and Indigenous women, who are three to four times more likely to die from pregnancy-related causes than white women. These disparities often persist regardless of income or education level, suggesting that systemic bias in clinical assessment plays a role. By standardizing the triage process through the PBTI, the medical community can introduce an objective framework that reduces the impact of implicit bias, ensuring every patient receives a high-standard assessment based on physiological data rather than subjective interpretation.
2. Redefining the "Fourth Trimester"
Historically, the medical community has viewed the end of pregnancy as the end of the "high-risk" period. The PBTI forces a paradigm shift, acknowledging that the year following birth is a distinct physiological state requiring specialized attention. This initiative encourages a more integrated healthcare system where the silos between obstetrics and emergency medicine are broken down.
3. Economic and Systemic Efficiency
Beyond the moral and clinical imperatives, the PBTI has the potential to reduce the economic burden on the healthcare system. Preventable complications that escalate into intensive care stays or long-term disabilities are incredibly costly. Early identification through standardized triage can lead to outpatient management or shorter hospitalizations, preserving hospital resources and reducing the overall cost of care.
4. A Template for Global Innovation
While the current grant focuses on the United States, the development of a validated PBTI could serve as a global blueprint. As Merck for Mothers (known as MSD for Mothers internationally) continues its work in other nations, the tools developed by AWHONN may eventually be adapted for use in diverse clinical settings worldwide, setting a new global standard for postpartum safety.
Conclusion
The $500,000 grant to AWHONN is more than a financial transaction; it is a catalyst for systemic change. By targeting the "gap" in emergency care, AWHONN and Merck for Mothers are addressing the most critical failure point in the American maternal health system. As the program moves toward its 2026 implementation, the goal remains clear: to ensure that no mother survives the perils of childbirth only to be lost to a preventable complication in the weeks that follow.
About AWHONN
The Association of Women’s Health, Obstetric and Neonatal Nurses (AWHONN) is a 501(c)3 nonprofit membership organization. Their mission is to empower and support nurses caring for women, newborns, and their families through research, education, and advocacy.
About Merck for Mothers
Merck for Mothers is a global initiative by Merck (known as MSD outside the U.S. and Canada) to help create a world where no woman has to die while giving life, investing in transformative solutions to improve maternal health outcomes.
Media Contact:
Shannon Doolin
202-261-2410
[email protected]
